Infectious Diseases Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Ebola Outbreak and Vaccination

A major outbreak of Ebola virus spreads through the West African nations of Guinea and Liberia.

Medicinal Mushrooms: Disease Fighters!

A significant number of modern prescription medications have been derived from mushrooms.

Vaccinating Immunodeficient Patients

Immunization with live viral or bacterial vaccines is known to be hazardous for vulnerable patient populations with serious immunodeficiencies.

Worst Measles Outbreak in 20 Years

Public health officials in Orange County, CA are reporting that a measles outbreak is the worst in two decades.

Noxafil New Formulation

Merck announced that the FDA has approved Noxafil injection, a new formulation of the antifungal agent Noxafil for intravenous (IV) use.

Gene Therapy May "Cure" HIV

Genome editing technology has been safely engineered to help provide resistance to HIV infection.

New Drug Product: Sovaldi

As a component of a combination antiviral treatment regimen for chronic hepatitis C (CHC) genotype 1, 2, 3, or 4 infection.

Chart: Community Acquired Pneumonia

Learn more with this clinical reference.

Videos

Clinical Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Calculators

Quickly and accurately perform clinical calculations.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Industry Supported Education

Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.

News

Pre-HPV Vaccine, Most Oropharyngeal Cancers HPV+

Most oropharyngeal cancers in the United States diagnosed between 1995-2005 were positive for human papillomavirus (HPV), specifically HPV 16 or 18.

NDA Submitted for All-Oral, Interferon-Free Hepatitis C Regimen

AbbVie has submitted a New Drug Application (NDA) to the FDA for an investigational, all-oral, interferon-free regimen for the treatment of adults with chronic genotype (GT1) hepatitis C virus (HCV) infection.

FDA Accepts Two NDAs for HIV Therapy

The FDA has accepted Gilead's New Drug Applications (NDAs) for cobicistat and elvitegravir for the treatment of HIV-1 infection in treatment-experienced adults.

Featured courses from mycme

Laws and Rules of the Florida Board of NursingExternal web site

This course reviews the purpose and membership of the Florida Board of Nursing (FBON), its ...

CE 2.00 Credits

Domestic Violence 3 Hour: Focus on Child Abuse for Kentucky Health ProfessionalsExternal web site

This course defines domestic violence as family violence, and further differentiates the categories of intimate ...

CE 3.00 Credits

Domestic Violence 3 Hour: Focus on Child Abuse for Florida Health ProfessionalsExternal web site

This course defines domestic violence as family violence, and further differentiates the categories of intimate ...

CE 3.00 Credits
More myCME courses »

Sign Up for Free e-newsletters